{Reference Type}: Letter
{Title}: [Pembrolizumab+chemotherapy as first-line treatment in patients with HER2 negative advanced oesogastric adenocarcinoma].
{Author}: Duval M;Zaanan A;
{Journal}: Bull Cancer
{Volume}: 111
{Issue}: 5
{Year}: 2024 May 7
{Factor}: 1.318
{DOI}: 10.1016/j.bulcan.2024.01.004